-
In 1988 he participated in an LBO and later changed the name to AmeriSource.
FORBES: Easy Pill to Swallow
-
Rx USA counterclaimed for breach of contract, maintaining that Amerisource had overcharged the company and failed to honor various discounts promised by a sales representative.
FORBES: Rx USA Hit With Sanctions Over Faked E-Mails
-
The antitrust claims were dismissed at the summary judgment stage, and the contract and tort claims that proceeded to trial were all decided in favor of Amerisource.
FORBES: Rx USA Hit With Sanctions Over Faked E-Mails
-
The lengthy litigation between the two parties stemmed from a dispute over prices for the inventory Amerisource sold to Rx USA for its retail and wholesale pharmacies.
FORBES: Rx USA Hit With Sanctions Over Faked E-Mails
-
Soon after the Federal Trade Commission cleared the merger of drug wholesalers AmeriSource and Bergen Brunswig in August, Chief Executive David Yost threw a dinner for 70 executives from both companies.
FORBES: Easy Pill to Swallow
-
Following the trial Amerisource sought sanctions against Rx USA and Drucker, who was not a party to the suit, contending that the company had used four e-mails altered by Drucker to support its claims that the companies had negotiated a discounted price for insulin.
FORBES: Rx USA Hit With Sanctions Over Faked E-Mails